TACE and other ADAM proteases as targets for drug discovery

This publication has 88 references indexed in Scilit:

• Metalloprotease‒disintegrin ADAM 12 binds to the SH3 domain of Src and activates Src tyrosine kinase in C2C12 cells
  Biochemical Journal, 2000
• Trafficking of Human ADAM 12-L: Retention in the trans-Golgi Network
  Biochemical and Biophysical Research Communications, 2000
• Evidence for an interaction of the metalloprotease‒disintegrin tumour necrosis factor α convertase (TACE) with mitotic arrest deficient 2 (MAD2), and of the metalloprotease‒disintegrin MDC9 with a novel MAD2-related protein, MAD2β
  Biochemical Journal, 1999
• Isolation of Two Novel Metalloproteinase-Disintegrin (ADAM) cDNAs That Show Testis-Specific Gene Expression
  Biochemical and Biophysical Research Communications, 1999
• An Essential Role for Ectodomain Shedding in Mammalian Development
  Science, 1998
• The Metallo-Disintegrin ADAM10 (MADM) from Bovine Kidney Has Type IV Collagenase Activityin Vitro
  Biochemical and Biophysical Research Communications, 1998
• KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-α production
  Life Sciences, 1997
• Expression of Members of the Novel Membrane Linked Metalloproteinase Family ADAM in Cells Derived from a Range of Haematological Malignancies
  Biochemical and Biophysical Research Communications, 1997
• Purification of ADAM 10 from bovine spleen as a TNFα convertase
  FEBS Letters, 1997
• Refined 2·0 Å X-ray Crystal Structure of the Snake Venom Zinc-endopeptidase Adamalysin II
  Journal of Molecular Biology, 1994